CASI PHARMACEUTICALS, INC. Share Repurchase Authorization
CASI PHARMACEUTICALS, INC. (CASIF) had Share Repurchase Authorization of $10.00 million as of 2021-12-15, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-05-15
- 2021-12-15: Stock Repurchase Program Authorized Amount1 $10.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2021-12-15 | $10.00M 20-F · filed 2026-05-15 |